Article Versions Notes

Lim YJ, Clarissa Lau PS, Low SX, Ng SL, Ong MY, Pang HM, Lee ZY, Yow HY, Hamzah SB, Sellappans R, et al. How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer? Drugs and Drug Candidates. 2023; 2(2):377-421. https://doi.org/10.3390/ddc2020020

Lim, Yu Jun, Pei Sze Clarissa Lau, Shi Xuan Low, Shong Li Ng, Min Yee Ong, Huey Ming Pang, Zheng Yang Lee, Hui Yin Yow, Sharina Binti Hamzah, Renukha Sellappans, and et al. 2023. "How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer?" Drugs and Drug Candidates 2, no. 2: 377-421. https://doi.org/10.3390/ddc2020020

Lim, Y. J., Clarissa Lau, P. S., Low, S. X., Ng, S. L., Ong, M. Y., Pang, H. M., Lee, Z. Y., Yow, H. Y., Hamzah, S. B., Sellappans, R., & Foo, J. B. (2023). How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer? Drugs and Drug Candidates, 2(2), 377-421. https://doi.org/10.3390/ddc2020020